Gunvor Secures US $1.39 Billion Revolving Credit Facility
Gunvor Group Ltd / Gunvor Secures US $1.39 Billion Revolving Credit Facility . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Strong bank support for Group strategy results in substantial over-subscription
GENEVA, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Gunvor Group Ltd ("Gunvor" or the "Group") has signed a US $1.39 billion Revolving Credit Facility ("RCF") in favour of Gunvor International B.V. and Gunvor SA (the "Borrowers"). The RCF, launched at US $1 billion, was substantially over-subscribed, drawing in US $1.81 billion, a record high for the facility. The RCF was scaled back to accommodate the needs of the Group, which will use the funds to finance general corporate purposes and working capital requirements.
"Gunvor continues to receive considerable support from both its existing banking partners as well as from new ones," said Jacques Erni, CFO, Gunvor Group. "Thanks to our continuous efforts to tighten cash management and improve financial structuring, we have become more efficient financially, with reduced working capital needs. At the same time, Gunvor continues to implement our strategy of geographic expansion and product diversification, generating positive returns in a challenging and evolving environment."
The RCF will replace the maturing Tranche A (US $1.415 billion) of the Borrowers' US $1.67 billion RCF dated 17 November 2016 and Tranche B (US $210 million) of the US $1.36 billion RCF dated 23 November 2015. The first RCF for Gunvor in Europe was launched in 2008 and is complemented by the Group's Asian Revolving Credit Facilities, Borrowing Base facilities, and OBSI Facility.
ABN AMRO Bank N.V., Credit Agricole Corporate and Investment Bank, Credit Suisse (Switzerland) Ltd, DBS Bank Ltd., ING Bank N.V., Natixis, Rabobank, Société Générale Corporate & Investment Banking, UBS Switzerland AG and UniCredit Bank AG (together the "Bookrunning Mandated Lead Arrangers") were mandated to arrange the Facility. ABN AMRO Bank N.V., Credit Agricole Corporate and Investment Bank, ING Bank N.V., Natixis and Rabobank acted as Active Bookrunners while Credit Suisse (Switzerland) Ltd is Facility and Swingline Agent.
Deutsche Bank AG, Amsterdam Branch, Mizuho Bank, Ltd, and Emirates NBD PJSC, London branch joined as Senior Mandated Lead Arrangers, with APICORP, Citigroup Global markets Limited, DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frank am Main, KfW-IPEX, Nedbank and Sumitomo Mitsui Trust Bank as Mandated Lead Arrangers.
The Bank of Tokyo-Mitsubishi UFJ, Limited, Commerzbank, Raiffeisen Bank International AG, and Sumitomo Mitsui Banking Corporation joined as Lead Arrangers, with Mashreqbank, Arab Bank (Switzerland) Ltd, Banco do Brasil, Bank ABC, Banque de Commerce et de Placements, Goldman Sachs, Gulf International Bank, Habib Bank AG Zurich, HSH Nordbank and UBAF as Arrangers, with Participants China Construction Bank, Beijing, Swiss Branch Zurich, Commercial Bank of Dubai, Garanti Bank International, Banque Cantonale de Genève, Attijariwafa Bank and Erste Bank AG.
The Facility consists of two tranches, available to Gunvor International B.V. and Gunvor SA:
- Tranche A: US $1.14 billion 364-day revolving credit facility with two 364-day extension options, and;
- Tranche B: US $250 million 3-year revolving credit facility with one 364-day extension option
About Gunvor Group
Gunvor Group is one of the world's largest independent commodities trading houses by turnover, creating logistics solutions that safely and efficiently move physical energy and bulk materials from where they are sourced and stored to where they are demanded most. With strategic investments in industrial infrastructure-refineries, pipelines, storage, terminals, mining and upstream-Gunvor further generates sustainable value across the global supply chain for its customers.
More information can be found at GunvorGroup.com or @Gunvor.
Mr. Seth Thomas Pietras
+41 79 870 62
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Gunvor Group Ltd via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
LeddarTech and Cailabs Sign Collaboration Agreement on Combining LiDAR and Laser Beam Shaping Solutions for the Automotive Market19.12.2018 06:05 | Pressemelding
RENNES, France and QUEBEC CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- LeddarTech, an industry leader providing the most versatile and scalable automotive LiDAR development platform, announces that it has entered an agreement with Cailabs, a French deep tech company and global leader in light shaping technology, to explore combining LeddarTech’s solid-state LiDAR technology with Cailabs’ laser beam shaping solutions for the automotive industry. A memorandum of understanding between the two parties was signed on December 13, 2018. LeddarTech delivers a proprietary auto and mobility LiDAR platform based on the LeddarEngine™ (SoC + software) enabling high-performance, low-cost LiDAR sensor solutions and that is used by large Tier-1 suppliers to develop specific LiDARs for ADAS and autonomous driving applications. Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular, Multi-Plane Light Conversion (MPLC)
Industry-leaders join BIOPAC for T4 Human Physiology Conference Set for August 12-14, 201919.12.2018 01:34 | Pressemelding
Training and Best Practices for Measuring Physiology GOLETA, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc., announced the second biennial T4 Human Physiology Conference to be held August 12-14, 2019 at the University of California Santa Barbara (UCSB). Life science researchers, educators, and students are invited to learn the latest Tools, Trends, Techniques, and Technology used in physiological measurement and interpretation. T4 sessions offer hands-on, practical tips and tricks, giving participants the latest tools and insights to pursue scientific discovery with significant amounts of data from multiple participants and devices, in or out of the lab. BIOPAC hosts the T4 Physiology Conference to increase understanding of physiological measurements. Frazer Findlay, BIOPAC CEO, says, “BIOPAC has always placed a strong emphasis on working with partners that understand the industry and the needs of our customers. I am delighted that we’ll have partners joining us at T4 t
RCI Banque S.A.: Post Stabilisation Notice18.12.2018 15:55 | Pressemelding
PARIS, Dec. 18, 2018 (GLOBE NEWSWIRE) -- 18th December 2018 RCI Banque S.A. Post Stabilisation Notice HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken in relation to RCI Banque S.A. GBP Fixed due 30th Oct 2023 because the transaction did not complete. Issuer: RCI Banque S.A. Guarantor (if any): NA Aggregate nominal amount: GBP Benchmark Description: Fixed due 30th Oct 2023 Offer price: na Stabilising Managers: HSBC, Lloyds, Natwest This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and condit
The North American Bitcoin Conference Stands Out as One of 2019’s Most Important Worldwide Crypto Events18.12.2018 15:35 | Pressemelding
MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire – 2019 will kick off with what has become widely accepted as one of the most important blockchain conferences of the year. The North American Bitcoin Conference, sponsored by Keynote and part of the World Blockchain Forum, will take place Jan. 16-18, 2019, at the James L. Knight Center in Miami, Florida. This premier crypto conference, now in its seventh year, will draw cryptocurrency and blockchain leaders from all across the globe as they come together for this historical event. The North American Bitcoin Conference is the longest-running, most-attended finance conference for the blockchain and crypto industries, with each event attracting thousands of attendees. The 2019 conference will feature a lineup of more than 60 world-class presenters, including technology veterans and company founders who have collectively raised more than $18.1 billion in initial coin offerings (ICOs). Speakers that have been announced thus far
Inspirata Subsidiary, Artificial Intelligence in Medicine (AIM), Signs Contract with the National Cancer Institute (NCI) to Use Its E-Path Reporter Software for Reporting by U.S. Central Cancer Registries18.12.2018 15:06 | Pressemelding
The NCI has licensed AIM’s E-Path Reporter software for the last 15 years to provide an automated solution that enables cancer registries to more efficiently collect and report cancer incidence and survival data. Toronto, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Artificial Intelligence In Medicine Inc. (AIM), an Inspirata company, announced today that the National Cancer Institute (NCI) has extended its license agreement for AIM’s E-Path Reporter software. The software has been licensed for use within the SEER (Surveillance, Epidemiology and End Results) program, for 14 central registries and 286 major reporting hospitals and laboratories across the U.S. NCI supports cancer data collection and research through the SEER program and publishes cancer statistics for 20 U.S. geographic areas. The NCI requires participating cancer registries to collect data on cancer patient demographics, primary tumor site, tumor morphology and disease stage at diagnosis. The registries also must report on fir
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services18.12.2018 14:30 | Pressemelding
Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening a new site in Suzhou, Jiangsu, China. The large amount of data now available from preclinical and clinical research requires specialized expertise in bioinformatics, big data analysis and dedicated storage facilities. CrownBio’s new site will focus on integrating the company’s experience in preclinical and translational research with cutting-edge digital technologies for the discovery of predictive biomarkers and the development of new and companion diagnostics. The Suzhou site will become CrownBio’s center of excellence for systems biology and clinical sample testing. Located at the heart of the Bi